Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 23Ovarian Neoplasms 18Neoplasm Metastasis 12Triple Negative Breast Neoplasms 9Prostatic Neoplasms 9Pancreatic Neoplasms 8Neoplasms 8Fallopian Tube Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Advanced Solid Tumors 4Small Cell Lung Carcinoma 3Recurrence 3Head and Neck Neoplasms 3Endometrial Neoplasms 3Carcinoma, Squamous Cell 3Solid Tumors 2Sarcoma 2Neuroendocrine Tumors 2Lymphoma 2Lung Neoplasms 2Hodgkin Disease 2Fanconi Anemia, Complementation Group D1 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumours 2Advanced Solid Tumor 2Advanced Cancer 2Triple Negative Metastatic Breast Cancer 1Thymoma 1Thrombocytosis 1Solid Tumor 1

Interventions

Fluorouracil 38Capecitabine 31Oxaliplatin 30Leucovorin 30Radiotherapy 21Irinotecan 20Bevacizumab 15Radiation 12Cetuximab 12pembrolizumab 9Gemcitabine 7trifluridine tipiracil drug combination 5dehydroftorafur 5cediranib 5Radiotherapy, Intensity-Modulated 5Folfox protocol 5Erlotinib Hydrochloride 5Cisplatin 5Carboplatin 5trametinib 4Surgical Procedures, Operative 4Paclitaxel 4Neoadjuvant Therapy 4Gene Expression Profiling 4Cyclophosphamide 4sargramostim 3binimetinib 3Trifluridine 3Sorafenib 3Pemetrexed 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Rectal Neoplasms × olaparib × Clear all
NCT00535353 2023-08-04

AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Canadian Cancer Trials Group

Phase 1 Completed
26 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡